Mild Cushing syndrome, now more commonly called mild autonomous cortisol secretion (MACS), is a condition in which an adrenal gland produces a small but persistent excess of cortisol without the dramatic physical changes associated with full-blown Cushing syndrome. It is far more common than classic Cushing syndrome and is typically discovered by accident when imaging for an unrelated problem reveals an adrenal mass. The tricky part is that the cortisol excess is subtle enough to fly under the radar of standard screening tests, yet substantial enough to quietly raise a person’s risk of high blood pressure, diabetes, bone loss, and cardiovascular disease over time.
What Makes It “Mild”
In overt Cushing syndrome, cortisol levels are high enough to cause visible signs: a round “moon” face, fat accumulation between the shoulders, thin skin with purple stretch marks, and muscle wasting. Mild Cushing syndrome skips most of those outward cues. The adrenal gland still overproduces cortisol, but at levels low enough that you and your doctor could easily attribute any symptoms to aging, stress, or other conditions. The term “subclinical Cushing syndrome” was used for years, and you will still see it in older literature, but the endocrine community has been shifting toward “mild autonomous cortisol secretion” because the word “subclinical” implies the condition is harmless, which growing evidence shows it is not.
The underlying mechanism involves adrenal nodules or areas of hyperplasia that produce cortisol on their own, outside the brain’s normal regulatory loop. In a healthy system, the pituitary gland releases a hormone called ACTH that tells the adrenal glands how much cortisol to make. When an adrenal nodule starts making cortisol independently, the pituitary responds by dialing ACTH down, partially suppressing the healthy adrenal tissue. The result is cortisol levels that may look close to normal on a single morning blood draw but show abnormal patterns over a full day, with levels staying elevated in the evening and overnight when they should be dropping.1The Journal of Clinical Endocrinology & Metabolism. Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement
How Common Is It
MACS is surprisingly prevalent, though exact numbers depend on which population you study and which diagnostic cutoffs you apply. When doctors scan the abdomen for something else entirely, they find adrenal nodules in roughly one to seven percent of people, and these incidentally discovered masses are called adrenal incidentalomas.2PubMed. Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches Among people with adrenal incidentalomas, about 20 to 50 percent meet criteria for MACS based on an abnormal overnight dexamethasone suppression test.3PubMed. Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches One study of 50 patients with adrenal incidentalomas found that 24 percent met criteria for subclinical Cushing syndrome, and that group had strikingly high rates of hypertension, diabetes, elevated lipids, and generalized obesity compared to those without cortisol excess.4PubMed. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features
These are not small numbers. As abdominal CT and MRI scans become more routine for other medical workups, more adrenal incidentalomas are being found, which means more cases of MACS are being identified. Many endocrinologists suspect that a significant number of people walking around with poorly controlled blood pressure, unexplained weight gain, or worsening blood sugar actually have undiagnosed mild cortisol excess from an adrenal nodule that nobody has looked for.
Why Diagnosis Is Difficult
The standard screening test for cortisol overproduction is the overnight 1-mg dexamethasone suppression test. You take a small steroid pill at bedtime, and your blood cortisol is measured the following morning. In a healthy person, the dexamethasone tells the pituitary to stop sending ACTH, and cortisol drops below a threshold. If it does not suppress, something is producing cortisol autonomously. The Endocrine Society recommends this test or a late-night cortisol measurement for suspected mild Cushing syndrome, favoring either over urine cortisol collection.5The Journal of Clinical Endocrinology & Metabolism. The Diagnosis of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline
The challenge is that the conventional cutoff for an abnormal result was designed mainly to catch overt Cushing syndrome, and it does not always perform well at the mild end of the spectrum. A recent analysis found that slightly adjusted cutoffs could improve sensitivity and specificity for MACS specifically.6PubMed Central. Optimizing Diagnostic Accuracy in Cushing Syndrome Using 1 mg Dexamethasone Suppression Test Cut-Offs Meanwhile, the dexamethasone suppression test is not infallible even for overt disease: one study found that 18 percent of patients with confirmed Cushing’s disease suppressed their cortisol below what was traditionally considered the “safe” cutoff on the overnight 1-mg test, meaning they would have been falsely cleared of the diagnosis.7The Journal of Clinical Endocrinology & Metabolism. The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing’s Syndrome
Other common tests have their own blind spots when it comes to MACS. Late-night salivary cortisol, which works well for overt Cushing syndrome, often comes back normal in MACS patients. One study found that about half of patients with confirmed MACS had normal salivary cortisol readings, so current guidelines do not recommend it as a standalone screen for this condition.8Journal of the Endocrine Society. Salivary Cortisone Measurement In Mild Autonomous Cortisol Secretion: Retrospective Single-center Cohort Study Similarly, a normal 24-hour urine cortisol collection does not rule out mild Cushing syndrome. The bottom line from the diagnostic research is that no single test reliably catches the condition on its own; multiple rounds of testing with different methods are usually needed.9PubMed. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome
Metabolic and Cardiovascular Damage
The health consequences of MACS are surprisingly similar to those of overt Cushing syndrome, just building more slowly and with less obvious signaling. Excess cortisol, even at modest levels, impairs the body’s ability to use insulin effectively and clear glucose from the blood, leading to higher fasting blood sugar and a greater risk of developing type 2 diabetes.10PubMed Central. Glucose metabolism in Cushing’s syndrome Cortisol also promotes visceral fat accumulation around the organs while breaking down skeletal muscle. Compared to people with adrenal masses that do not produce hormones, MACS patients carry significantly more visceral fat and have reduced muscle mass, with both measures worsening as cortisol levels after dexamethasone go up.11PubMed Central. Abnormal body composition in patients with adrenal adenomas
Hypertension is common in this population. Cortisol excess triggers high blood pressure through several overlapping mechanisms, including effects on blood vessel reactivity and kidney sodium handling, and the resulting cardiovascular strain contributes to the increased mortality associated with Cushing syndrome overall.12PubMed Central. The hypertension of Cushing’s syndrome: controversies in the pathophysiology and focus on cardiovascular complications Cardiac imaging research has found that the heart changes seen in MACS patients, including thickening and functional impairment, are comparable to those seen in overt Cushing syndrome, which suggests that even low-grade cortisol excess takes a real toll on the heart over time.13European Heart Journal – Cardiovascular Imaging. Mild autonomous cortisol secretion portends similar cardiac compromise as overt endogenous Cushings syndrome
Bone and Muscle Effects
Cortisol at any dose above normal accelerates bone breakdown and slows bone formation. In MACS, the erosion is subtle and occurs in a way that standard bone density scans may not catch. One study using a tool called the trabecular bone score, which assesses the internal microarchitecture of bone rather than just overall density, found that MACS patients had significantly deteriorated bone quality compared to people with non-functioning adrenal tumors, even though their standard density measurements looked similar. Bone quality worsened in step with the intensity of cortisol excess.14PubMed. Assessment of vertebral microarchitecture in overt and mild Cushing’s syndrome using trabecular bone score This is a practical problem: a person with MACS might be told their bone density is fine after a routine scan, missing the hidden structural weakness that raises their fracture risk.
MACS patients also tend to be frailer than people with non-functioning adrenal masses. Reviews of the evidence note higher disability, worse quality of life, and increased stress and sleep disturbances.15PubMed. Mild autonomous cortisol secretion: impact on bone health and quality of life. A review The combination of muscle loss and impaired bone quality compounds fall and fracture risk, particularly in older adults.
Does Mild Cushing Syndrome Affect the Brain
Cortisol receptors are dense in brain regions involved in memory, attention, and mood regulation, so it would be surprising if chronic mild excess left the brain untouched. In overt Cushing syndrome, patients frequently report attention problems, memory difficulties, and mood changes. A study of adults with Cushing syndrome found that the most common complaints were difficulty sustaining attention and increased irritability. Objective testing confirmed impairments in sustained attention and in the ability to learn new visual and verbal information on first exposure. Nearly 60 percent of patients scored in the clinically elevated range for depression and somatic symptom distress.16PubMed Central. Neuropsychological and Emotional Functioning in Patients with Cushing’s Syndrome
Research specifically in MACS patients is thinner, but the pattern is consistent with what clinicians see in practice: middle-of-the-night insomnia, increased perceived stress, and higher levels of mental-health-related disability compared to people with adrenal masses that do not make extra cortisol.17PubMed. Mild autonomous cortisol secretion: impact on bone health and quality of life. A review These symptoms are often attributed to aging, life circumstances, or a mood disorder and treated accordingly, without anyone checking cortisol.
Does It Progress to Full-Blown Cushing Syndrome
This is one of the more reassuring aspects of the condition. Despite the name “subclinical,” which once implied that it was a stepping stone to overt disease, the evidence suggests that progression to full Cushing syndrome happens rarely, if ever.18PubMed. Subclinical Cushing’s syndrome The real danger of MACS is not that it escalates into dramatic cortisol overproduction. It is that it silently contributes to cardiovascular disease, metabolic syndrome, and fractures for years while nobody connects those dots back to a quiet little adrenal nodule.
Treatment: Surgery Versus Watchful Management
The treatment decision in MACS centers on whether the metabolic harm from low-grade cortisol excess justifies surgery to remove the adrenal gland harboring the nodule. A meta-analysis comparing surgery to conservative management found that adrenalectomy led to meaningful improvements across the board: lower blood pressure, better blood sugar control, reduced waist circumference, and improved lipid levels compared to patients managed without surgery.19PubMed Central. Evaluating the efficacy of surgical and conservative approaches in mild autonomous cortisol secretion: a meta-analysis A randomized trial found that diabetes improved or resolved in about 63 percent of surgical patients, and hypertension improved or resolved in 67 percent, while the conservatively managed group saw some worsening of those same conditions over time.20Annals of Surgery. Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study
Surgery is not the right answer for everyone. Not all patients have a single, clearly responsible nodule. Some have bilateral adrenal disease, meaning both glands are affected, and removing one does not necessarily fix the problem. Older patients or those with significant surgical risk may be better served by managing the metabolic consequences with standard medications for blood pressure, blood sugar, and cholesterol. The decision depends on the severity of the cortisol excess, the burden of metabolic complications, and the patient’s overall fitness for surgery.
What Happens After Surgery
One aspect that catches patients off guard is adrenal insufficiency after the operation. When an adrenal nodule has been pumping out cortisol on its own for years, the opposite adrenal gland partially shuts down because the pituitary has been reducing its ACTH signal. Once the overactive gland is removed, the remaining gland needs time to wake back up. During this recovery period, patients require replacement steroid medication to avoid dangerously low cortisol levels.
For MACS patients, recovery tends to be faster than for those with overt Cushing syndrome. A prospective cohort study found that the median time to recovery from adrenal insufficiency was about four months in MACS patients, compared to roughly 13 to 14 months in patients with overt disease.21PubMed Central. Duration of adrenal insufficiency after surgical treatment of endogenous hypercortisolism: a prospective cohort study However, patients with higher pre-surgical cortisol after dexamethasone testing were about four times more likely to still need steroid replacement beyond one year.22PubMed. Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretion This means the post-operative recovery is not trivial and requires close endocrine follow-up, especially around times of physical stress like illness or injury, when cortisol demand spikes.
Emerging Medical Therapies
For patients who are not candidates for surgery or who have cortisol excess from both adrenal glands, there is growing interest in medications that block cortisol production directly. Medical therapy to lower cortisol offers an alternative when surgery is contraindicated or when the patient prefers a non-surgical route.23PubMed. The impact of mild autonomous cortisol secretion and proposed interventions
One drug getting attention is metyrapone, which blocks an enzyme involved in cortisol synthesis. A proof-of-concept trial in MACS patients found that evening doses of metyrapone reduced liver fat and improved the overall metabolic risk profile.24PubMed Central. Metabolic effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a prospective proof-of-concept trial Separate research showed that metyrapone also dampened the pro-inflammatory immune profile seen in MACS, reducing markers tied to chronic inflammation and immune dysregulation.25European Journal of Endocrinology. P455 – LBA_ECE_1092 – Metyrapone treatment improves the pro-inflammatory profile in patients with mild autonomous cortisol secretion These results are still early-stage, but they point toward a future where MACS patients who cannot or do not want to undergo surgery have a pharmaceutical option that addresses the root hormonal problem rather than just treating downstream symptoms like high blood pressure or high blood sugar one by one.
When to Suspect MACS in Yourself or a Family Member
There is no simple self-test for MACS, and the condition does not produce a characteristic appearance the way overt Cushing syndrome does. What should raise a flag is a cluster of metabolic problems that seem out of proportion to a person’s lifestyle or that resist standard treatments. If someone has high blood pressure that requires three or more medications, type 2 diabetes that worsened rapidly despite reasonable diet and exercise, unexplained osteoporosis (particularly vertebral fractures found incidentally), and maybe persistent fatigue or mood changes on top of it all, the combination is worth investigating further. This is especially true if any imaging study has ever incidentally shown an adrenal mass, even a small one that was dismissed as unimportant at the time.
The conversation to have with a doctor is straightforward: ask whether an overnight dexamethasone suppression test has been considered. It is a simple, inexpensive screen. The catch is that a single normal result does not completely rule out the diagnosis, so if suspicion is high, repeat testing or additional evaluation may be warranted. The larger point is that MACS tends to be found only when someone thinks to look for it, and the metabolic consequences of missing it compound over years.